2 results
Approved WMORecruiting
Assess the potential efficay of L-serine dietary supplementation in patients children with a GRIN2B LoS mutation.
Approved WMORecruiting
Primary objectivePhase I: To determine the recommended phase II dose (RP2D) of the combination treatment with nivolumab and entinostat administered to adolescents 12-21 years with progressive, relapsed , refractory high-risk solid tumors and CNS…